NIH-funded research R01 grant

Understanding how HPV interacts with the body's DNA damage response

Official title: Interplay between the cellular DNA damage response and the HPV life cycle

Funded at Univ of North Carolina Chapel Hill · NIH-11066532 · Data updated 2026-11-12

This study is looking at how high-risk HPV infections affect the way our cells handle DNA damage, with the goal of finding new treatments for cancers caused by HPV, so that patients can have better options for managing their health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startMay 18, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$403,970
NIH project number5R01AI173039-03
Project IDNIH-11066532 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with persistent high-risk HPV infections or HPV-related cancers.

Less likely to help

Patients who do not have HPV infections or related cancers are unlikely to benefit from this research.

What this research studies

This research investigates the relationship between high-risk human papillomavirus (HPV) infections and the cellular mechanisms that respond to DNA damage. By studying how HPV manipulates the DNA damage response to enhance its own replication, the research aims to uncover new therapeutic strategies for treating HPV-related cancers. The approach involves examining the roles of specific proteins, such as RNF168 and BRCA1, in the viral life cycle and how they may be targeted for antiviral drug development. Patients may benefit from insights that could lead to effective antiviral therapies for HPV-related diseases.

Why it matters

Potential benefit: If successful, this research could lead to the development of novel antiviral treatments for cancers caused by HPV.

How similar studies have gone: Previous research has shown promise in targeting viral interactions with the DNA damage response, suggesting potential for success in this area.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Moody, Cary a — Univ of North Carolina Chapel Hill
  • Study coordinator: Moody, Cary a

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.